Insulin degludec in Japanese patients with type 1 diabetes mellitus: A randomized controlled trial

INTRODUCTION: Insulin degludec is an ultra‐long‐acting insulin with a flat time‐action profile and duration of action >42 h. Data from several studies have shown insulin degludec to have a favorable therapeutic profile in type 1 and type 2 diabetes. MATERIALS AND METHODS: This was a 6‐week, paral...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Yasuhiko, Clauson, Per, Nishida, Tomoyuki, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019289/
https://www.ncbi.nlm.nih.gov/pubmed/24843632
http://dx.doi.org/10.1111/j.2040-1124.2012.00240.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019289/
https://www.ncbi.nlm.nih.gov/pubmed/24843632
http://dx.doi.org/10.1111/j.2040-1124.2012.00240.x

Ejemplares similares